Kenneth Pienta

Zitiert von

	Alle	Seit 2016
Zitate	70543	27965
h-index	131	77
i10-index	447	318

7000

3500

1750

5250

1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021217 231 379 273 335 420 512 511 840 1117 1417 1527 1746 2063 2585 2706 3037 3436 4022 4373 4647 4767 4924 4984 5379 5363 6212 1061

Koautoren

Mark A RubinProfessor & Director Department for BioMedical Research, University of BernBestätigte E-Mail-Adresse bei dbmr.unibe.ch
Russell S. TaichmanUniversity of Michigan School of DentistryBestätigte E-Mail-Adresse bei umich.edu
Scott TomlinsAssociate Professor of Pathology and UrologyBestätigte E-Mail-Adresse bei umich.edu
Rajal B. ShahDr. Charles T. Ashworth Professor of Pathology, University of Texas Southwestern Medical CenterBestätigte E-Mail-Adresse bei utsouthwestern.edu
Robert LobergRoche DiagnosticsBestätigte E-Mail-Adresse bei amgen.com
Saravana M DhanasekaranResearch ScientistBestätigte E-Mail-Adresse bei umich.edu
Laurie K McCauleyuniversity of michiganBestätigte E-Mail-Adresse bei umich.edu
steven roweBestätigte E-Mail-Adresse bei jhmi.edu
Michael A. Gorin, M.D.Urology Associates & UPMC Western Maryland, Cumberland, MDBestätigte E-Mail-Adresse bei urologyassociatesmd.com
younghun jungAssistant Research ScientistBestätigte E-Mail-Adresse bei umich.edu
Debashis GhoshProfessor and Chair, Colorado School of Public HealthBestätigte E-Mail-Adresse bei ucdenver.edu
Sarah R AmendJohns Hopkins UniversityBestätigte E-Mail-Adresse bei jhmi.edu
James E VerdoneMedical Student, Drexel UniversityBestätigte E-Mail-Adresse bei drexel.edu
Phuoc T. Tran, MD, PhDJohns Hopkins Medicine, Depts. Radiation Oncology, Oncology and UrologyBestätigte E-Mail-Adresse bei jhmi.edu
Martin G SandaProfessor and Chairman of Urology, Emory University School of MedicineBestätigte E-Mail-Adresse bei emory.edu
Mario EisenbergerProfessor of Oncology,Johns Hopkins UniversityBestätigte E-Mail-Adresse bei jhmi.edu
Daniel RhodesUniversity of Michigan, Compendia Bioscience, Life TechnologiesBestätigte E-Mail-Adresse bei lifetech.com
Emmanuel S. Antonarakis, M.D.Professor of Oncology and Urology, Johns Hopkins UniversityBestätigte E-Mail-Adresse bei jhmi.edu
Jianhua WangChina Institute of Water Resources and Hydropower Research (IWHR)Bestätigte E-Mail-Adresse bei iwhr.com
Mohamad AllafJohns HopkinsBestätigte E-Mail-Adresse bei jhmi.edu

Kenneth Pienta

Professor of Urology, Oncology, Pharmacology and Molecular Sciences, Johns Hopkins University

Bestätigte E-Mail-Adresse bei jhmi.edu - Startseite

tumor biology metastasis ecology evolution cancer treatment


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ... science 310 (5748), 644-648, 2005	4094	2005
The polycomb group protein EZH2 is involved in progression of prostate cancer S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ... Nature 419 (6907), 624-629, 2002	2726	2002
Integrative clinical genomics of advanced prostate cancer D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ... Cell 161 (5), 1215-1228, 2015	2121	2015
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer JS De Bono, HI Scher, RB Montgomery, C Parker, MC Miller, H Tissing, ... Clinical cancer research 14 (19), 6302-6309, 2008	2037	2008
Delineation of prognostic biomarkers in prostate cancer SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ... Nature 412 (6849), 822-826, 2001	1963	2001
The mutational landscape of lethal castration-resistant prostate cancer CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ... Nature 487 (7406), 239-243, 2012	1933	2012
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone RS Taichman, C Cooper, ET Keller, KJ Pienta, NS Taichman, ... Cancer research 62 (6), 1832-1837, 2002	1179	2002
Integrative molecular concept modeling of prostate cancer progression SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ... Nature genetics 39 (1), 41-51, 2007	958	2007
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ... Nature 448 (7153), 595-599, 2007	883	2007
Activating ESR1 mutations in hormone-resistant metastatic breast cancer DR Robinson, YM Wu, P Vats, F Su, RJ Lonigro, X Cao, ... Nature genetics 45 (12), 1446, 2013	852	2013
α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer MA Rubin, M Zhou, SM Dhanasekaran, S Varambally, TR Barrette, ... Jama 287 (13), 1662-1670, 2002	808	2002
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ... Cancer cell 8 (5), 393-406, 2005	775	2005
CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression X Sun, G Cheng, M Hao, J Zheng, X Zhou, J Zhang, RS Taichman, ... Cancer and Metastasis Reviews 29 (4), 709-722, 2010	709	2010
Autoantibody signatures in prostate cancer X Wang, J Yu, A Sreekumar, S Varambally, R Shen, D Giacherio, R Mehra, ... New England Journal of Medicine 353 (12), 1224-1235, 2005	706	2005
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition S Shangary, D Qin, D McEachern, M Liu, RS Miller, S Qiu, ... Proceedings of the National Academy of Sciences 105 (10), 3933-3938, 2008	705	2008
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program RB Shah, R Mehra, AM Chinnaiyan, R Shen, D Ghosh, M Zhou, ... Cancer research 64 (24), 9209-9216, 2004	656	2004
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth Q Wang, W Li, XS Liu, JS Carroll, OA Jänne, EK Keeton, AM Chinnaiyan, ... Molecular cell 27 (3), 380-392, 2007	642	2007
Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument P Esper, FEI Mo, G Chodak, M Sinner, D Cella, KJ Pienta Urology 50 (6), 920-928, 1997	608	1997
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data HI Scher, X Jia, JS de Bono, M Fleisher, KJ Pienta, D Raghavan, G Heller The lancet oncology 10 (3), 233-239, 2009	603	2009
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow Y Shiozawa, EA Pedersen, AM Havens, Y Jung, A Mishra, J Joseph, ... The Journal of clinical investigation 121 (4), 1298-1312, 2011	601	2011

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

PDF hochladen

Diesem Autor folgen

Zitiert von

Koautoren